Trials / Completed
CompletedNCT03443219
RCT- LMA Supreme™ Versus the Spritztube® Tracheal Cannula in Anesthetized Adult Patients
A Prospective Randomised Controlled Trial of the LMA Supreme™ Versus the Spritztube® Tracheal Cannula in Anesthetized Adult Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 355 (actual)
- Sponsor
- St. Bortolo Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study compares the LMA Supreme™ versus the Spritztube® tracheal cannula in anesthetized adult patients. The current randomized study is designed to assess the success placement of blind insertion using LMA Supreme™ , in comparison with the Spritztube® tracheal cannula. In addition, time, number of attempts, easy insertion and the number of complications at insertion and removal will be assessed. The investigators hypothesize that the LMA Supreme™ versus the Spritztube® tracheal cannula will similarly perform during anesthetized adult patients despite differences in their structural design.
Detailed description
A new extraglottic airway device, the Spritztube® \[tracheal cannula, Med Europe s.r.l\], was developed combining the ability to perform both EAD ventilation and oro-tracheal fibreoptic intubation using the same device. The Spritztube® consists of a silicone cannula with two low-pressure cuffs: a proximal cuff, designed to seal the pharynx cranially of the epiglottis and a distal cuff, designed to seal the oesophagus. The positioning of this device requires the aid of a spindle, that keep the cuffs on the same line and it is rigid enough to allow the passage through oropharynx tissue. That can be inserted blindly as extraglottic device or through the use of direct laryngoscopy or fibroscopy as tracheal cannula. The current randomized study is designed to assess the success placement of blind insertion using LMA Supreme™ , in comparison with the Spritztube® tracheal cannula. In addition, time, number of attempts, easy insertion and the number of complications at insertion and removal will be assessed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Spritztube® | After preoxygenation, anaesthesia was induced with midazolam, propofol, and fentanyl,Spritztube® was inserted and both cuffs inflated |
| DEVICE | LMA Supreme™ | After preoxygenation, anaesthesia was induced with midazolam, propofol, and fentanyl,LMA Supreme™ was inserted and both cuffs inflated |
Timeline
- Start date
- 2016-09-15
- Primary completion
- 2017-07-10
- Completion
- 2017-10-20
- First posted
- 2018-02-23
- Last updated
- 2018-02-23
Source: ClinicalTrials.gov record NCT03443219. Inclusion in this directory is not an endorsement.